Phase II Study of Vinflunine in Malignant Pleural Mesothelioma


2007-12-28 12:39

Vinflunine shows encouragin sings for treatment in Malignant Pleural Mesothelioma.

Malignant pleural mesothelioma (MPM) is a disease of increasing incidence for which treatment options are limited. This study reports the clinical efficacy data for vinflunine, a novel microtubule inhibitor, in MPM.

Patients and Methods: Patients with a histologically confirmed diagnosis of